Conor McNamara

Stock Analyst at RBC Capital

(0)
# 4933
Out of 5,438 analysts
124
Total ratings
Success rate
Average return
14 Stocks
Name Action PT Current % Upside Ratings Updated
MRVI Maravai LifeSciences
Maintains: Outperform
7 5
2.05 143.9% 7 Aug 12, 2025
NTRA Natera
Maintains: Outperform
251 255
157.12 62.3% 2 Aug 8, 2025
OABI OmniAb
Maintains: Outperform
4 3
1.97 52.28% 4 Aug 7, 2025
EXAS Exact Sciences
Maintains: Sector Perform
54 46
40.92 12.41% 1 Aug 7, 2025
TECH Bio-Techne
Maintains: Sector Perform
63 61
50.16 21.61% 10 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
72 87
68 27.94% 12 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 17
12.11 40.38% 9 Aug 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
118 126
94.79 32.93% 16 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
387 409
264.24 54.78% 12 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
193 204
111.93 82.26% 12 Jul 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
651 637
462.25 37.8% 14 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
250 250
199.79 25.13% 10 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
64 61
23.65 157.93% 11 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
8 7
3.02 131.79% 4 Aug 7, 2024